The STING pathway and cytosolic nucleic acid sensors in bone homeostasis
骨稳态中的 STING 通路和胞质核酸传感器
基本信息
- 批准号:9383723
- 负责人:
- 金额:$ 36.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-19 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AIM2 geneAddressAge-Related Bone LossAgingApoptoticAutoimmune DiseasesAutoimmunityBacterial DNABacterial InfectionsBindingBiological AssayBone MarrowBone remodelingCASP1 geneCell LineageCellsChIP-seqComplexCyclic GMPCytosolDNADNA DamageDataDegradation PathwayDendritic CellsExhibitsFOS geneGene Expression ProfilingGenesGenomeGrantHistologyHomeostasisHuman GenomeIRF3 geneImmuneImmune responseImmune systemInfectionInflammasomeInterferon Type IInterferon-betaInterferonsInterleukin-1 betaInterleukin-18LigandsLinkMass Spectrum AnalysisMediator of activation proteinMusNucleic AcidsOrganismOsteoclastsOsteopeniaOxidesPathologicPathway interactionsPattern recognition receptorPhenotypeProcessProductionProteinsRegulationRegulatory ElementRetroelementsRoleSignal TransductionSourceStressStructure-Activity RelationshipTNFSF11 geneTestingTimeToll-like receptorsViralVirus Diseasesacid stressbonebone lossbone massbone turnovercell typecortical bonecytokineds-DNAgene inductionin vivoinsightmacrophagemicrobialmonocytemutantnano-stringnew therapeutic targetnovelosteoclastogenesisprecursor cellpreventreceptorsensorskeletalsubstantia spongiosatomography
项目摘要
PROJECT SUMMARY/ABSTRACT
Innate immune sensors detect nucleic acid from viral and bacterial infections to clear infection, and also
recognize endogenous (self) nucleic acid from stressed or dying cells. Toll-like receptors have long
been known to detect nucleic acid, while nucleic acid s ensors within the cytosol have only recently been
discovered. Importantly, activation of cytosolic DNA sensor pathways has been shown to promote
autoimmune disease. Endogenous sources of DNA within cells can activate these pathways, including
oxidized, “damaged” DNA that accrues with aging and can escape degradation, as well as DNA derived
from replication of endogenous retroelements within the human genome. Despite the importance of the
cytosolic DNA sensor pathways, little is known about their role in cell types other than macrophages and
dendritic cells. We now demonstrate an important role for these pathways in bone that may
provide insight into the bone loss occurring with aging and in certain autoimmune diseases. Several
cytosolic DNA sensors signal through an ER-associated protein stimulator of interferon genes (STING),
the most important of which is cyclic GMP-AMP synthase (cGAS). Activation of STING results in the
production of type I interferons and other mediators. The cytosolic DNA sensor AIM2 does not signal
through STING, but instead coordinates the assembly of an inflammasome complex, resulting in the
activation of IL-1β and IL-18. We demonstrate that the STING and AIM2 pathways differentially regulate
bone: STING deficient mice develop an osteopenic phenotype, implicating STING as a protective pathway
for bone during states of DNA challenge such as viral and bacterial infection, while AIM2 deficiency
enhances cortical and trabecular bone mass. We hypothesize that the STING and AIM2 pathways
differentially regulate OC differentiation/function through distinct mechanisms. In Aim 1 we will
determine the cell-intrinsic role of the STING pathway in the inhibition of osteoclast differentiation and
the role of type I interferon and downstream regulatory elements in this process. In Aim 2 we will test the
hypothesis that cytosolic DNA regulates bone homeostasis through the STING pathway, and
determine the specific role of the critical DNA sensor cGAS upstream of STING in the regulation of
osteoclastogenesis. Aim 3 will determine the role of the AIM2 inflammasome in regulating OC
differentiation/function and will define interactions between the AIM2 and STING pathways. This
proposal addresses the entirely novel hypothesis that cytosolic DNA sensors and their ligands regulate
bone remodeling and aims to define the distinct pathways by which this occurs. Data generated should
provide new therapeutic targets for the protection from pathologic bone remodeling in aging and
autoimmunity.
项目总结/摘要
先天免疫传感器检测来自病毒和细菌感染的核酸以清除感染,
Toll样受体能识别来自应激或死亡细胞的内源性(自身)核酸。
已经知道检测核酸,而细胞质内的核酸传感器只是最近才被发现。
重要的是,细胞溶质DNA传感器通路的激活已被证明可以促进
细胞内DNA的内源性来源可以激活这些途径,包括
氧化的,“受损”的DNA,随着年龄的增长,可以逃脱降解,以及DNA衍生
从复制内源性逆转录因子在人类基因组中。尽管重要的是,
细胞溶质DNA传感器途径,很少有人知道他们的作用,在细胞类型以外的巨噬细胞和
我们现在证明了这些通路在骨中的重要作用,
提供了深入了解骨质流失发生与老化和某些自身免疫性疾病。几个
胞质DNA传感器通过干扰素基因的ER β相关蛋白刺激物(STING)发出信号,
其中最重要的是环GMP-cAMP合酶(cGAS)。
产生I型干扰素和其他介质。胞质DNA传感器AIM 2不发出信号
通过STING,而是协调炎性小体复合物的组装,导致
我们证明STING和AIM 2通路对IL-18和IL-19 β的激活有不同的调节作用。
骨:STING缺陷小鼠出现骨质减少表型,暗示STING是一种保护性途径
在DNA挑战状态下,如病毒和细菌感染,而AIM 2缺陷
我们假设STING和AIM 2通路可以增强骨皮质和骨小梁的质量。
通过不同的机制差异调节OC分化/功能。在目标1中,我们将
确定STING途径在抑制破骨细胞分化中的细胞内固有作用,
I型干扰素和下游调节元件在这一过程中的作用。在目标2中,我们将测试
假设胞质DNA通过STING途径调节骨稳态,
确定STING上游的关键DNA传感器cGAS在调节
目的3将确定AIM 2炎性小体在调节OC中的作用
本发明的目的是提供一种新的细胞分化/功能,并将定义AIM 2和STING途径之间的相互作用。
该提案提出了细胞质DNA传感器及其配体调节的全新假设
骨重建,目的是确定这发生的不同途径。生成的数据应
提供了新的治疗靶点,用于防止衰老中的病理性骨重建,
自身免疫
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ellen M Gravallese其他文献
Safety of CAR T-cell therapy for cancer in pre-existing autoimmune or inflammatory disease: a retrospective comparative cohort study
嵌合抗原受体(CAR)T细胞疗法用于存在自身免疫性或炎症性疾病患者癌症治疗的安全性:一项回顾性对比队列研究
- DOI:
10.1016/s2665-9913(24)00402-8 - 发表时间:
2025-04-01 - 期刊:
- 影响因子:16.400
- 作者:
Kathleen M M Vanni;Kaitlin R McCarter;Xiaosong Wang;Caitlyn Duffy;Jamie P Dela Cruz;Holly Wobma;Sarah Nikiforow;Elena M Massarotti;Karen H Costenbader;Jessica S Little;Ellen M Gravallese;Gregory C McDermott;Caron A Jacobson;Jeffrey A Sparks - 通讯作者:
Jeffrey A Sparks
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023
风湿病领域未满足的需求:2023年靶向治疗进展会议报告
- DOI:
10.1136/ard-2023-224916 - 发表时间:
2024-04-01 - 期刊:
- 影响因子:20.600
- 作者:
Kevin L Winthrop;Philip Mease;Andreas Kerschbaumer;Reinhard E Voll;Ferdinand C Breedveld;Josef S Smolen;Jacques-Eric Gottenberg;Xenofon Baraliakos;Hans P Kiener;Daniel Aletaha;John D Isaacs;Maya H Buch;Mary K Crow;Jonathan Kay;Leslie Crofford;Ronald F van Vollenhoven;Caroline Ospelt;Stefan Siebert;Margreet Kloppenburg;Iain B McInnes;Ellen M Gravallese - 通讯作者:
Ellen M Gravallese
Ellen M Gravallese的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ellen M Gravallese', 18)}}的其他基金
Novel approaches to promote healing of bone loss in inflammatory arthritis
促进炎症性关节炎骨质流失愈合的新方法
- 批准号:
10365023 - 财政年份:2022
- 资助金额:
$ 36.85万 - 项目类别:
Novel approaches to promote healing of bone loss in inflammatory arthritis
促进炎症性关节炎骨质流失愈合的新方法
- 批准号:
10590694 - 财政年份:2022
- 资助金额:
$ 36.85万 - 项目类别:
Novel approaches to the treatment of bone loss in rheumatoid arthritis
治疗类风湿性关节炎骨质流失的新方法
- 批准号:
9572399 - 财政年份:2017
- 资助金额:
$ 36.85万 - 项目类别:
Novel approaches to the treatment of bone loss in rheumatoid arthritis
治疗类风湿性关节炎骨质流失的新方法
- 批准号:
9435618 - 财政年份:2017
- 资助金额:
$ 36.85万 - 项目类别:
The STING pathway and cytosolic nucleic acid sensors in bone homeostasis
骨稳态中的 STING 通路和胞质核酸传感器
- 批准号:
10190834 - 财政年份:2017
- 资助金额:
$ 36.85万 - 项目类别:
The STING pathway and cytosolic nucleic acid sensors in bone homeostasis
骨稳态中的 STING 通路和胞质核酸传感器
- 批准号:
10115967 - 财政年份:2017
- 资助金额:
$ 36.85万 - 项目类别:
Regulatory role for cytosolic nucleic acid sensors in bone
细胞质核酸传感器在骨中的调节作用
- 批准号:
8808584 - 财政年份:2014
- 资助金额:
$ 36.85万 - 项目类别:
Regulatory role for cytosolic nucleic acid sensors in bone
细胞质核酸传感器在骨中的调节作用
- 批准号:
8919245 - 财政年份:2014
- 资助金额:
$ 36.85万 - 项目类别:
Inhibition of osteoblast function in bone erosion in rheumatoid arthritis
类风湿性关节炎骨侵蚀中成骨细胞功能的抑制
- 批准号:
8098159 - 财政年份:2009
- 资助金额:
$ 36.85万 - 项目类别:
Inhibition of osteoblast function in bone erosion in rheumatoid arthritis
类风湿性关节炎骨侵蚀中成骨细胞功能的抑制
- 批准号:
8493996 - 财政年份:2009
- 资助金额:
$ 36.85万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 36.85万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 36.85万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 36.85万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 36.85万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 36.85万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 36.85万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 36.85万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 36.85万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 36.85万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 36.85万 - 项目类别:
Research Grant